drugset
drugset / Trial / NCT01975272

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

NCT01975272 ↗

Phase 4 Terminated 27 enrolled Maastricht University Medical Center Vifor Pharma · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether oral or intravenous iron is effective in the treatment of anaemia (iron-poor blood) after caesarean section.

Timeline

Start
2015-03-02
Primary completion
2018-05-17
Completion
2018-06-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 200 mg Oral

Indications

No indication recorded.